Opinions are my own & do not rep NIA/NIH/HHS

Joined March 2018
Great opportunity!!! @interneurona could you share it between your #LATAM colleagues???
1
6
1,748
Kimberley has done an amazing job standing up high throughput long read sequencing at CARD….
Today we heard from Kimberley on utilising long nanopore reads to sequence ~4,000 human brain clinical research samples, to further understand Alzheimer’s disease and related dementias #nanoporeconf
8
1,980
love this collaboration!
Our own @C_WSolsberg @halsty and friends from NIH CARD 🧬 identify novel AD loci by leveraging diversity across populations @UCSFmac
1
1
6
1,944
Been a great day for publications from the team. @mkoretsky1 and the team great job on showing genetic overlap and in some instances a depletion of genetic risk across and within neurodegenerative diseases. – at Nashville, TN
Genetic risk factor clustering within and across neurodegenerative conditions (such as #Parkinsons, #Alzheimers, #ALS) - from @HamptonLLeonard & colleagues; "Neurodegenerative diseases have more overlapping genetic etiology than previously expected" academic.oup.com/brain/advan…
1
6
13
3,019
Dramatic improvement for @nanopore DRS using kits RNA004 vs RNA002 @NUBioE1 a) Human poly-A RNA alignment identity: 2019 (RNA002, 86%), 2022 (RNA002, 89.8%), 2023 (RNA004, 95.6%) b) Human MT poly-A RNA read alignments (2019 vs 2023). Colored lines = base mismatches @AkesonUCSC
6
34
2
104
17,826
Pssst, next GP2 release in ~2 weeks 🤐. Release 5 for Cinco de Mayo (well a few days after). – at Bethesda, MD
3
7
1,005
41 novel targets, network insights and potential tox inferences ... #opensource #openscience ... app here nih-card-ndd-smr-home-syboky…. Awesome work from Chelsea X. A. (sensibly twitter averse) to leverage public resource to do this (thx @OpenTargets and other for the APIs)!
2
6
713
New preprint from the team at CARD, nominating novel drug targets for neurodegenerative disease using multi-omic and genetic data. Hoping this is a starting point for community target discovery specifically focused on ADRD. medrxiv.org/content/10.1101/…
1
17
2
43
8,063
Funding opportunity! GP2 is co-funding two places for @movedisorder Aspen Course. If you are an early career Movement Disorders Fellow who identifies as belonging to an underrepresented group in #PD research, we encourage you to apply. Deadline is 5/1: pulse.ly/4uqz6ymutl
2
1
706
Great presentation of @mario_cornejo_o in #IIIcongressobrasileironeurogenetica @LARGE_PD @ASAP_Research @arturschuh @nachogenePD – at Sao Paulo, Brazil
1
4
1
13
971
I wrote a blog post for International Women's Day, featuring women in #datascience and #neuroscience at @NIHAging's Center for #Alzheimers and related dementias! card.nih.gov/news-events/car… #scicomm #InternationalWomensDay
5
6
15
5,274
🎉In case you missed it📢 BLAAC-PD is expanding to six sites, allowing the initiative to continue to grow its partnerships with traditionally underrepresented populations and helping to unlock the genetic architecture of #ParkinsonsDisease. michaeljfox.org/publication/…
1
4
431
If you are a doctor or scientist based in Africa, Asia or Latin America interested in getting a master's in clinical neurology or data science via distance learning @ucl or @UMBC, apply for GP2 support! Learn more: gp2.org/opportunities/?utm_s…
1
10
11
1,706
📢 Apply to get trained in data science while working with a ton of talented and motivated scientists on Alzheimer’s and related dementias research at #CARD ! 📢 🤩
This Post is from an account that no longer exists. Learn more
1
4
684
A nice thread here:
BREAKING NEWS: New #Alzheimer drug #Lecanemab slows cognitive decline (18-month change in CDR-SB) by 27%, drastically lowers brain amyloid load by 59 centiloids to 23 (below PET amyloid positivity)! NEJM paper: nejm.org/doi/full/10.1056/NE… prnewswire.com/news-releases… #CTAD
2
7
It’s quafftide somewhere. Here in fact.
Word of the day is ‘quafftide’(16th century): a one-word announcement that it’s time for a drink.
2
a fantastic resource....really excited to support this work through CARD at the NIH IRP. Next comes the exciting part...
New batch of engineered iPSC lines from JAX/iNDI, including much-requested APOE variants! Isogenic sets of APOE2, 3, 4, and Christchurch variants, plus revertant controls, all deeply QC'd and available with a clickable online MTA. jax.org/jax-mice-and-service…
4
Anyone dug around in their GP2 tier2 buckets lately? If so, how's new data in release 3 (its live already in your workspace 😈). R3 is official very soon (couple weeks), keep your eyes on the GP2 blog. Epic teamwork from too many (some on this call)! #OpenScience
1
4
10